Start Schlagworte EMBL Ventures

Schlagwort: EMBL Ventures

New funding concepts for ­translational projects

The biotech scene in Germany is growing continuously – slowly but steadily, despite the ongoing shortcomings of the ­European risk capital market. While funding...

Topas erzielt Serie A-Finanzierung von 14 Mio. EUR

Die Topas Therapeutics GmbH, spezialisiert auf die Erforschung von Autoimmunkrankheiten, hat eine Serie A-Finanzierungsrunde in Höhe von 14 Mio. EUR abschließen können.

ViraTherapeutics: First closing of Series A financing

ViraTherapeutics (ViraT), a privately held biopharmaceutical company developing cancer immunotherapies based on cancer-destroying viruses, announces the first closing of a Series A financing round, raising 3,6 Mio. EUR.